NOVONIX Ltd (NVX) director Sharan Burrow adds 31,250 shares at $0.16

Q: What insider transaction did NOVONIX (NVX) report for Sharan Burrow?

NOVONIX reported that director Sharan Burrow acquired 31,250 ordinary shares on 2026-07-22 . The transaction used Form 4 code J , labeled as an "other" acquisition or disposition of non-derivative securities.

Q: At what price were the NOVONIX (NVX) shares acquired by Sharan Burrow?

The reported acquisition price was $0.16 per ordinary share for the 31,250 shares . This per-share price is explicitly identified as such in the filing’s data and applies to the entire reported transaction.

Q: Was the NOVONIX (NVX) insider transaction by Sharan Burrow under a Rule 10b5-1 plan?

The filing shows the Rule 10b5-1 checkbox as not selected , indicating the reported transaction is not affirmed as made under a pre-arranged Rule 10b5-1 trading plan framework.

Q: What does transaction code J mean in the NOVONIX (NVX) Form 4 for Sharan Burrow?

Transaction code J on the Form 4 denotes an "other" acquisition or disposition type. In this case, the Form 4 data classifies Burrow’s 31,250-share ordinary-share change as such an "other" non-derivative acquisition.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

NOVONIX Ltd director Sharan Burrow reported acquiring 31,250 ordinary shares on 2026-07-22 in an "other" acquisition (transaction code J) at $0.16 per share. Following this transaction, Burrow directly holds 246,989 ordinary shares. The Rule 10b5-1 trading-plan checkbox is not marked.

Insider Trade Summary

Net Buyer: 31,250 shares

Net Buy 1 txn

Insider Burrow Sharan

Role Director

Type	Security	Shares	Price	Value
Other	Ordinary shares	31,250	$0.16	$5K

Holdings After Transaction: Ordinary shares — 246,989 shares (Direct)

Key Figures

Shares acquired: 31,250 ordinary shares Price per share: $0.16 Total shares after transaction: 246,989 ordinary shares

3 metrics

Shares acquired 31,250 ordinary shares Non-derivative acquisition on 2026-07-22, transaction code J

Price per share $0.16 Reported transaction_price_per_share for the 31,250-share acquisition

Total shares after transaction 246,989 ordinary shares Direct ownership following the reported acquisition

Key Terms

Ordinary shares, Rule 10b5-1, Form 4

3 terms

Ordinary shares financial

"The security title is reported as "Ordinary shares" for this transaction."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Rule 10b5-1 regulatory

"The Rule 10b5-1 trading-plan checkbox is present and not selected."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Form 4 regulatory

"Insider transactions are reported for this officer on Form 4."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/23/2026 - 06:27 PM Accepted by SEC EDGAR 07/23/2026 - 06:26 PM

FAQ

What insider transaction did NOVONIX (NVX) report for Sharan Burrow?

NOVONIX reported that director Sharan Burrow acquired 31,250 ordinary shares on 2026-07-22. The transaction used Form 4 code J, labeled as an "other" acquisition or disposition of non-derivative securities.

At what price were the NOVONIX (NVX) shares acquired by Sharan Burrow?

The reported acquisition price was $0.16 per ordinary share for the 31,250 shares. This per-share price is explicitly identified as such in the filing’s data and applies to the entire reported transaction.

How many NOVONIX (NVX) shares does Sharan Burrow hold after this Form 4 transaction?

After the reported acquisition, Sharan Burrow directly holds 246,989 ordinary shares of NOVONIX. This total reflects the Form 4 data labeled "total_shares_following_transaction" for the non-derivative ordinary-share holding.

Was the NOVONIX (NVX) insider transaction by Sharan Burrow under a Rule 10b5-1 plan?

The filing shows the Rule 10b5-1 checkbox as not selected, indicating the reported transaction is not affirmed as made under a pre-arranged Rule 10b5-1 trading plan framework.

What does transaction code J mean in the NOVONIX (NVX) Form 4 for Sharan Burrow?

Transaction code J on the Form 4 denotes an "other" acquisition or disposition type. In this case, the Form 4 data classifies Burrow’s 31,250-share ordinary-share change as such an "other" non-derivative acquisition.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burrow Sharan

(Last)

(First)

(Middle)

1029 WEST 19TH STREET

(Street)

CHATTANOOGA

TENNESSEE

37408

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NOVONIX Ltd [ NVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary shares	07/22/2026		J		31,250	A	$0.16	246,989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Suzanne Yeates	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR